A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1)
Sponsor: Eli Lilly & Co.
Phase:
Disease: B-cell malignancies
EU trial number: 2025-524180-20-00
Population: Adult participants with previously treated B-cell malignancies. The available CTIS record does not specify individual hematologic disease subtypes, treatment lines, biomarker thresholds or detailed eligibility criteria.
Register Investigator Interest
Interested in offering this trial to suitable patients?